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Autoimmune hepatitis (AIH) is a chronic inflammation of
the liver caused by an abnormal autoimmune reaction
against hepatocytes. The pathogenesis of AIH involves a
loss of tolerance to hepatic self antigens in a susceptible
host. The diagnosis is based on histological abnormalities,
and characteristic clinical and biochemical findings, which
include abnormal levels of serum globulins, and the pre-
sence of one or more characteristic autoantibodies such as
ANA, SMA, and anti-SLA. Interface hepatitis with abun-
dant plasma cells in the infiltrate is characteristic histologi-
cal features of AIH. Although the prevalence data are
scare, AIH has emerging as major course of non-viral
chronic hepatitis in China. More and more liver centers
launch liver biopsy and serum autoantibody detection
regularly. Alertness and awareness of hepatologists and
histologic physicians on histologic features of AIH contri-
butes to more and more AIH patients diagnosed in our
clinics who were considered as cryptogenic chronic hepati-
tis previously. The simplified criteria have high sensitivity
and specificity for diagnosis of AIH in Chinese patients.
The revised original criteria have the complementary role
to avoid the false negative diagnosis in atypical AIH
patients. Immunosuppressive treatment can attenuate
hepatic inflammation, revert fibrosis, and eventually
improve the patient’s prognosis and life quality. Corticos-
teroids, either alone or in combination with azathioprine,
are the standard treatment of choice for AIH. Most
Chinese patients with AIH show a good response to immu-
nosuppressive treatment, although patients with late-stage
or severe disease are less likely to achieve remission. Liver
transplantation is the last choice for AIH patients with
decompensated end-stage disease. Transfer of regulatory
immune cells such as regulatory T cells may become a
potential therapy in the near future.
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